Carson Wealth (CWM LLC)
GMAB icon

Carson Wealth (CWM LLC)’s Genmab GMAB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233K Buy
8,668
+5,929
+216% +$178K ﹤0.01% 2602
2025
Q4 		$84K Buy
2,739
+433
+19% +$13.5K ﹤0.01% 3199
2025
Q3 		$71K Buy
2,306
+509
+28% +$12.4K ﹤0.01% 3235
2025
Q2 		$37K Buy
1,797
+603
+51% +$12.4K ﹤0.01% 3498
2025
Q1 		$23K Sell
1,194
-820
-41% -$17.2K ﹤0.01% 3564
2024
Q4 		$42K Buy
2,014
+712
+55% +$15.6K ﹤0.01% 2928
2024
Q3 		$32K Buy
1,302
+316
+32% +$8.45K ﹤0.01% 3051
2024
Q2 		$25K Buy
986
+101
+11% +$2.86K ﹤0.01% 2967
2024
Q1 		$26K Sell
885
-11,144
-93% -$327K ﹤0.01% 2729
2023
Q4 		$383K Sell
12,029
-1,727
-13% -$54.2K ﹤0.01% 1160
2023
Q3 		$485K Buy
13,756
+759
+6% +$28.9K ﹤0.01% 988
2023
Q2 		$494K Buy
12,997
+2,598
+25% +$104K ﹤0.01% 943
2023
Q1 		$393K Buy
10,399
+2,867
+38% +$110K ﹤0.01% 964
2022
Q4 		$319K Sell
7,532
-1,500
-17% -$61.8K ﹤0.01% 934
2022
Q3 		$290K Sell
9,032
-1,646
-15% -$57.8K ﹤0.01% 917
2022
Q2 		$347K Sell
10,678
-2,697
-20% -$87.4K ﹤0.01% 843
2022
Q1 		$484K Sell
13,375
-3,394
-20% -$116K ﹤0.01% 742
2021
Q4 		$663K Buy
+16,769
New +$699K ﹤0.01% 660
2021
Q2 		$823K Hold
20,155
– – 0.01% 598
2021
Q1 		$823K Hold
20,155
– – 0.01% 598
2020
Q4 		$823K Hold
20,155
– – 0.01% 598
2020
Q3 		$823K Hold
20,155
– – 0.01% 598
2020
Q2 		$823K Hold
20,155
– – 0.01% 598
2020
Q1 		$823K Hold
20,155
– – 0.01% 598
2019
Q4 		$823K Hold
20,155
– – 0.01% 598
2019
Q3 		$823K Buy
+20,155
New +$397K 0.01% 598

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Carson Wealth (CWM LLC)'s GMAB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Genmab (GMAB) stake by 216% in Q1 2026, buying an estimated $178K and bringing the position to 8,668 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

Carson Wealth (CWM LLC) first reported a position in GMAB in Q3 2019 and has held it in 26 quarters since. The position peaked at $823K in Q2 2021. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 8,668 shares of Genmab worth $233K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 5,929 Genmab shares in Q1 2026, an estimated $178K.
  • Genmab made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2602 holding.
  • Carson Wealth (CWM LLC) first reported a position in Genmab in Q3 2019 and has held it in 26 quarters since.
  • Carson Wealth (CWM LLC)'s Genmab position peaked at $823K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.